Intuitive Surgical (ISRG) Stock Price
Intuitive Surgical Price
Over the last 19 years Intuitive Surgical grew revenue by 18.9% annually, reaching 10.06 B USD. Earnings per share have grown at 20.9% per year over the last 19 years. For Intuitive Surgical, the net margin of 28.4% is down versus 29.9% a few years ago. The consensus 12-month price target for Intuitive Surgical is 493.50 USD, about 16.7% above where the stock trades today. Of 40 analysts, 29 rate the stock a buy — an overall Buy consensus.
Intuitive Surgical stock price
Intuitive Surgical business model & stock analysis
Frequently asked questions about Intuitive Surgical
The business model of Intuitive Surgical Inc. revolves around the development, manufacturing, and marketing of robotic-assisted surgical systems. Intuitive Surgical's flagship product, the da Vinci Surgical System, enables surgeons to perform minimally invasive surgery with enhanced precision, control, and visualization. By combining robotics, software, and surgical expertise, Intuitive Surgical aims to provide innovative solutions that improve patient outcomes, reduce surgical complexity, and enhance the capabilities of healthcare professionals. Intuitive Surgical Inc. continually invests in research and development to expand its product portfolio and remains committed to supporting surgeons and hospitals worldwide in delivering advanced surgical care.
Intuitive Surgical Inc is primarily active in the medical device and healthcare industries.
Intuitive Surgical Inc faces competition from companies such as TransEnterix Inc, Medtronic Plc, and Johnson & Johnson in the market.
Intuitive Surgical Inc is a renowned American company specializing in robotic-assisted surgical systems. Founded in 1995, the company has a rich history of innovation and is widely recognized for its flagship product, the da Vinci Surgical System. This advanced technology revolutionized minimally invasive surgery by providing surgeons with enhanced precision and control. Intuitive Surgical Inc has continuously improved its robotic systems over the years, expanding its applications to various surgical specialties. The company's commitment to research, development, and training has positioned it as a global leader in robotic surgery, benefiting both patients and healthcare professionals worldwide.
Intuitive Surgical Inc has achieved several significant milestones. One notable achievement was the development of the da Vinci Surgical System, a groundbreaking robotic surgical platform that enables surgeons to perform minimally invasive procedures with enhanced precision. The company also introduced the da Vinci Xi System, which offers expanded capabilities and versatility. Moreover, Intuitive Surgical Inc has expanded its global presence by installing over 5,500 da Vinci Systems worldwide. These milestones have solidified Intuitive Surgical Inc's position as a leader in robotic-assisted surgery, providing advanced technology that improves patient outcomes and revolutionizes the healthcare industry.
Intuitive Surgical Inc primarily operates in various countries and regions worldwide. The company has a strong presence in the United States, where it is headquartered. Additionally, Intuitive Surgical Inc has established a significant market presence in Europe, particularly in countries like Germany, France, and the United Kingdom. The company also operates in other parts of the world, including Australia, Japan, China, and South Korea. With its innovative robotic surgical systems and instruments, Intuitive Surgical Inc continues to expand its global footprint, delivering advanced healthcare solutions to patients and healthcare professionals across different regions.
Intuitive Surgical Inc represents values and a corporate philosophy centered around innovation, patient care, and technological advancements in the field of robotic-assisted surgery. As a leading company in the medical industry, Intuitive Surgical Inc is committed to improving surgical outcomes, enabling minimally invasive procedures, and enhancing the overall patient experience. With their flagship product, the da Vinci Surgical System, Intuitive Surgical Inc has revolutionized the way complex surgeries are performed. By combining their cutting-edge technology and a dedication to continuous improvement, Intuitive Surgical Inc strives to provide healthcare professionals with tools that optimize surgical precision, efficiency, and ultimately, patient outcomes.
Analysts currently set an average price target of 491.15 USD for the Intuitive Surgical stock (median: 493.50 USD), implying +16.1 % versus the latest price. The consensus is based on 40 analyst ratings.
40 analysts currently rate the Intuitive Surgical stock: 29 recommend buying, 10 holding and 1 selling. For 2026, analysts expect Intuitive Surgical to generate revenue of 11.76 B USD and earnings per share of 10.64 USD.
Converted at the current exchange rate, the Intuitive Surgical share trades at 377.49 EUR (423.01 USD).
The Intuitive Surgical share (ISRG) is listed on 13 stock exchanges, including: NASDAQ (ISRG), London (0R29.L), SIX (Zürich) (ISRG.SW), XETRA (IUI1.DE), Frankfurt (IUI1.F), München (IUI1.MU), Stuttgart (IUI1.SG), Düsseldorf (IUI1.DU).
Intuitive Surgical Inc. is a leading company specializing in medical technology, focused on the development and manufacture of robotic systems for surgical procedures. The company is headquartered in Sunnyvale, California and was founded in 1995.
The expected revenue of Intuitive Surgical is 11.76 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Intuitive Surgical is 3.84 B USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Intuitive Surgical is currently 39.75. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Intuitive Surgical stock.
The price-to-sales ratio (P/S) of Intuitive Surgical is currently 12.96. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Intuitive Surgical stock.
The Eulerpool Quality Score for Intuitive Surgical is 7/10.
The ISIN of Intuitive Surgical is US46120E6023. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Intuitive Surgical is 888024. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Intuitive Surgical is ISRG. The ticker symbol is used to trade Intuitive Surgical shares on the stock exchange.
Intuitive Surgical stock
Intuitive Surgical Peer Group
Intuitive Surgical Ticker
Intuitive Surgical FIGI
All fundamentals and in-depth analysis of Intuitive Surgical
Our stock analysis for Intuitive Surgical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Intuitive Surgical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.